Evidence map›Paper›PMID 39752523›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

Mitochondrial DNA lineages determine tumor progression through T cell reactive oxygen signaling.

Tal Yardeni, Arnold Z Olali, Hsiao-Wen Chen, Liqing Wang, Jeffrey A Haltom, Angi Zenab, Ryan Morrow, Arrienne Butic, Deborah G Murdock, Katrina G Waymire and 5 more

Erratum issuedAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Functional tumor-reactive CD8 + T cells in pancreatic cancer.Journal of experimental & clinical cancer research : CR · 2025
    Article
  6. Review
  7. Mitochondrial DNA lineages determine tumor progression through T cell reactive oxygen signaling.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  8. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Tal YardeniCenter for Mitochondrial and Epigenomic Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA 19104.
Arnold Z OlaliCenter for Mitochondrial and Epigenomic Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA 19104.
Hsiao-Wen ChenCenter for Mitochondrial and Epigenomic Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA 19104.
Liqing WangDivision of Transplant Immunology, Children's Hospital of Philadelphia and Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104.
Jeffrey A HaltomCenter for Mitochondrial and Epigenomic Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA 19104.
Angi ZenabBert Strassburger Metabolic Center for Preventive Medicine, Sheba Medical Center, Tel Hashomer 5262000, Israel.
Ryan MorrowCenter for Mitochondrial and Epigenomic Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA 19104.
Arrienne ButicCenter for Mitochondrial and Epigenomic Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA 19104.
Deborah G MurdockCenter for Mitochondrial and Epigenomic Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA 19104.
Katrina G WaymireDepartment of Developmental and Cell Biology, Charlie Dunlop School of Biological Sciences, University of California, Irvine, CA 92697-2300.
Grant R MacGregorDepartment of Developmental and Cell Biology, Charlie Dunlop School of Biological Sciences, University of California, Irvine, CA 92697-2300.
Ben BoursiDivision of Oncology, Sheba Medical Center, Tel-Hashomer, Tel-Aviv University, Tel Aviv 5262000, Israel.ORCID 0000-0002-1304-8340
Ulf H BeierImmunology, Johnson & Johnson Innovative Medicine, Spring House, PA 19477.
Wayne W HancockCenter for Mitochondrial and Epigenomic Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA 19104.ORCID 0000-0002-7211-5291
Douglas C WallaceCenter for Mitochondrial and Epigenomic Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA 19104.ORCID 0000-0002-7480-8278

Funding

Univ.of Calif., Irvine Cancer Center Support GrantP30CA062203 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Melanie Funes · 1994 to 2026
$57.9M
Role of Adaptive Immunity in Etiology of Alzheimer’s Disease andAlzheimer’s Disease-Related DementiasR01AG078814 · NIA · CHILDREN'S HOSP OF PHILADELPHIA · PI Douglas C Wallace · 2022 to 2026
$4.2M
Anti-tumor immunity and intestinal microbiota are modulated by mitochondrial DNAR01CA259635 · NCI · CHILDREN'S HOSP OF PHILADELPHIA · PI Douglas C Wallace · 2022 to 2026
$3.2M
HHS | NIH | National Cancer Institute (NCI) P30CA062203HHS | NIH | National Institute on Aging (NIA) RO1AG078814HHS | NIH | NCI | Division of Cancer Epidemiology and Genetics (DCEG) RO1CA259635NCI NIH HHS P30 CA062203NCI NIH HHS R01 CA259635NIA NIH HHS R01 AG078814
6 · The paper itself

Abstract

Mitochondrial DNA (mtDNA) is highly polymorphic, and host mtDNA variation has been associated with altered cancer severity. To determine the basis of this mtDNA-cancer association, we analyzed conplastic mice with the C57BL/6J (B6) nucleus but two naturally occurring mtDNA lineages,

Indexed as

DNA, MitochondrialMice, Inbred C57BLReactive Oxygen SpeciesT-Lymphocytes, RegulatoryAnimalsDisease ProgressionHeart TransplantationMiceMitochondriaOxidative PhosphorylationSignal TransductionDNA, MitochondrialReactive Oxygen Speciesadoptive transfercancerimmunotherapymitochondrial DNAreactive oxygen species

Identifiers

PMID39752523
PMCPMC11725793

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.